Acurx Pharmaceuticals, Inc. Effective Tax Rate
Acurx Pharmaceuticals, Inc. (ACXP) reported Effective Tax Rate of 0.00% for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateContinuingOperations · last filed 2026-08-13
- Acurx Pharmaceuticals, Inc. effective income tax rate reconciliation, percent for the quarter ending 2026-03-31 was 0.00%.
- Acurx Pharmaceuticals, Inc. effective income tax rate reconciliation, percent for the quarter ending 2025-03-31 was 0.00%.
- Acurx Pharmaceuticals, Inc. effective income tax rate reconciliation, percent for the quarter ending 2024-09-30 was 0.00%.
- Acurx Pharmaceuticals, Inc. effective income tax rate reconciliation, percent for the quarter ending 2024-06-30 was 0.00%.
- Acurx Pharmaceuticals, Inc. effective income tax rate reconciliation, percent for fiscal 2025 was 0.00%.
- Acurx Pharmaceuticals, Inc. effective income tax rate reconciliation, percent for fiscal 2024 was 0.00%.
- Acurx Pharmaceuticals, Inc. effective income tax rate reconciliation, percent for fiscal 2023 was 0.00%.
- Acurx Pharmaceuticals, Inc. effective income tax rate reconciliation, percent for fiscal 2022 was 0.00%.
| Period end | Effective Income Tax Rate Reconciliation, Percent 3 month | Effective Income Tax Rate Reconciliation, Percent 6 month | Effective Income Tax Rate Reconciliation, Percent 9 month | Effective Income Tax Rate Reconciliation, Percent 12 month |
|---|---|---|---|---|
| 2026-06-30 | 0.00% 10-Q · filed 2026-08-13 | |||
| 2026-03-31 | 0.00% 10-Q · filed 2026-05-11 | |||
| 2025-12-31 | 0.00% 10-K · filed 2026-03-12 | |||
| 2025-09-30 | 0.00% 10-Q · filed 2025-11-12 | |||
| 2025-06-30 | 0.00% 10-Q · filed 2025-08-11 | |||
| 2025-03-31 | 0.00% 10-Q · filed 2025-05-12 | |||
| 2024-12-31 | 0.00% 10-K · filed 2026-03-12 | |||
| 2024-09-30 | 0.00% 10-Q · filed 2024-11-12 | 0.00% 10-Q · filed 2024-11-12 | ||
| 2024-06-30 | 0.00% 10-Q · filed 2024-08-08 | 0.00% 10-Q · filed 2024-08-08 | ||
| 2024-03-31 | 0.00% 10-Q · filed 2024-05-14 | |||
| 2023-12-31 | 0.00% 10-K · filed 2025-03-17 | |||
| 2023-09-30 | 0.00% 10-Q · filed 2023-11-13 | |||
| 2023-06-30 | 0.00% 10-Q · filed 2023-08-11 | |||
| 2023-03-31 | 0.00% 10-Q · filed 2023-05-12 | |||
| 2022-12-31 | 0.00% 10-K · filed 2024-03-15 | |||
| 2022-09-30 | 0.00% 10-Q · filed 2022-11-10 | |||
| 2022-06-30 | 0.00% 10-Q · filed 2022-08-12 | |||
| 2022-03-31 | 0.00% 10-Q · filed 2022-05-10 | |||
| 2021-12-31 | 0.00% 10-K · filed 2022-03-16 | |||
| 2021-09-30 | 0.00% 10-Q · filed 2021-11-12 | |||
| 2021-06-30 | 0.00% 10-Q · filed 2021-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Pulmatrix, Inc. (PULM) | United States | $0.006B |